Published on
May 16, 2023
- 13:51 GMT
Immunophotonics Receives Green Light from FDA to Open Investigational New Drug (IND) Study for IP-001 in the U.S.
ST. LOUIS, MISSOURI, USA, May 16, 2023 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel innate immune stimulating drugs with antigen depot properties, has announced the U.S. …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
